Consistent with increased reovirus products in the BZ-resistant cells and in agreement with our data generated in primary CD138+ cells isolated from MM patients, BZ-resistant cell lines displayed significantly higher levels of JAM-A expression compared to parental cells as measured by qRT-PCR and immunoblotting (Figures 5D and 5E). The gene discussed is SDC1; the disease is Miyoshi myopathy.